Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Takeda’s haemophilia A drug yields positive Phase IIIb/IV data

Adynovate is an antihemophilic factor (recombinant), PEGylated therapy for haemophilia A. Credit: Andrew Mason.



  • Takeda’s Adynovate Phase IIIb/IV data

Go Top